Comparing the Effects of Febuxostat and Allopurinol in an Animal Model of Metabolic Syndrome
Conclusion: Xanthine oxidase inhibitors ameliorated the effects of MS. Febuxostat was mildly superior to allopurinol in lowering serum fasting glucose, lipids, uric acid, and antioxidant enzyme activities.Pharmacology
Source: Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Allopurinol | Antidoxidants | Diets | Drugs & Pharmacology | Insulin | Metabolic Syndrome | Nutrition | Study | Urology & Nephrology